Industry News

More Industry News

Image title

Bayer Schering unveils expansion plan in Asia-Pacific
3/12/2010
Nigerian startup works to combat counterfeit drugs
3/12/2010
Study: Avastin fails to boost combo's efficacy in prostate cancer
3/12/2010

Bayer Schering unveils expansion plan in Asia-Pacific

3/12/2010

Bayer Schering Pharma will make a major investment in its operations in Asia-Pacific "to become stronger in the market and to have the support to be able to grow above the market," said Alok Kanti, head of Bayer Schering's Asian-Pacific unit. The firm plans to boost its workforce in Vietnam and South Korea and double the size of its sales staff in India.

Regulatory News

Image title

Bayer lung treatment gains FDA's orphan-drug status
3/11/2010
Debiopharm's 6-month dose of Trelstar obtains FDA approval
3/11/2010
FDA approves Sun's generic form of cancer drug Eloxatin
3/11/2010

Bayer lung treatment gains FDA's orphan-drug status

3/11/2010

The FDA gave orphan-drug designation to a powdered form of lung infection medicine ciprofloxacin that is being developed by Bayer HealthCare. Bayer hopes to market the drug to treat Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Online Newsletters

Kudos to companies extending themselves with superior manufacturing practices
02/10/2010
Boosting manufacturing efficiency: A look at new industry efforts
01/13/2010
Outsourcing API manufacturing – is the tide turning away from Asia?
12/09/2009
New CDC report, old lesson: Sterility in manufacturing is crucial
11/11/2009

As a Registered INTERPHEX365 Subscriber, you will be receiving monthly INTERPHEX365 Reporter newsletters electronically. This online publication, published in cooperation with SmartBrief, will summarize the highlights of each month with unique commentary on the industry news.

Issues of past monthly newsletters will be stored here in an Archive.

If you haven't already done so, we encourage you to Register to take full advantage of site functionality, including industry news and participation in the Business Discussion Forums.

Sign-up to receive the INTERPHEX365 Reporter